Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SIGA Technologies Inc. - Common Stock (NQ: SIGA )

6.140 +0.090 (+1.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SIGA Technologies Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
A New BioTech Research Race Is Focused On Improving Life For MS Patients
When the world is focused on a global pandemic no one saw coming four years ago, the attention given to escalating diseases with no known cure can be hidden from the public consciousness. This is... 
Via Benzinga
Dear Revlon (REV) Stock Fans, Prepare for Delisting
REV stock will be delisted soon. Revlon's shares will trade on an over-the-counter market, though they will likely eventually be worthless. 
Via InvestorPlace
SIGA Updates on Progress Its Smallpox Drug Trials For Potential Use Against Monkeypox
Via Benzinga
SIGA Technologies Bags New DoD Contract For Monkeypox Treatment
Via Benzinga
RIDE Stock Alert: Lordstown Motors Just Hit Key EV Milestone
Lordstown Motors (RIDE) stock is sliding lower on Thursday even after announcing commercial production of its Endurance pickup truck. 
Via InvestorPlace
What Is Going on With Sobr Safe (SOBR) Stock Today?
Sobr Safe (SOBR) stock is falling on Friday after announcing the pricing of a $6 million private placement with institutional investors. 
Via InvestorPlace
SIGA Announces $16M Procurement Orders For Its Monkeypox Treatment
Via Benzinga
Researchers Behind COVID-19 RECOVERY Trial Launch New Monkeypox Treatment Trial
Via Benzinga
SIGA Stock Alert: Siga Technologies Receives $11 Million Order for Monkeypox Drug
The price action in SIGA stock is counterintuitive today as the shares are down even while Siga Technologies locks down a lucrative contract. 
Via InvestorPlace
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
As cases of the monkeypox virus continue to grow, the race is on for a way to fight this once-rare disease.  Since the first reports of monkeypox infection in the United States started popping up in... 
Via Benzinga
FedEx, UPS And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning after recording losses in the previous session. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
Meet Our Satanist Monkeypox Czar
Since our leaders are repeating their AIDS tack of not trying to rein in the irresponsible individuals spreading this disease, we’re left with America’s preferred response: pharmaceuticals. 
Via Talk Markets
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,700 Today
SIGA Technologies (NASDAQ:SIGA) has outperformed the market over the past 5 years by 26.33% on an annualized basis producing an average annual return of 36.11%. Currently, SIGA Technologies has a... 
Via Benzinga
3 Picks That Could Be the Next Meme Stock Champion
If you are looking for the next meme stock champion, here are three picks that are not AMC, Bed Bath & Beyond or GameStop. 
Via InvestorPlace
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
Via Benzinga
Why Several Chinese Stocks Traded Higher; Here Are 58 Biggest Movers From Yesterday
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world.... 
Via Benzinga
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply. 
Via Benzinga
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
Via Benzinga
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments. 
Via Benzinga
WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant
Via Benzinga
Jim Cramer Says Sell This Stock As It's 'Up Too Much'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Waste Management Inc (NYSE: WM) is the "bull’s bull." 
Via Benzinga
$1000 Invested In SIGA Technologies 5 Years Ago Would Be Worth This Much Today
  SIGA Technologies (NASDAQ:SIGA) has outperformed the market over the past 5 years by 39.87% on an annualized basis producing an average annual return of 51.66%. Currently, SIGA Technologies has a... 
Via Benzinga
A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring
Blue Water Vaccines Inc (NASDAQ: BWV)  
Via Benzinga
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. 
Via InvestorPlace
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand
Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide, 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.